Lee Wood - Mar 1, 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Mar 1, 2023
Transactions value $
-$32,173
Form type
4
Date filed
3/3/2023, 04:00 PM
Previous filing
Feb 22, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +39.8K +115.71% $0.00 74.2K Mar 1, 2023 Direct F1
transaction MD Common Stock Tax liability -$32.2K -2.04K -2.75% $15.74 72.2K Mar 1, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
F2 Represents 2,044 restricted shares withheld for payment of taxes upon vesting of shares.